Literature DB >> 8870611

ADHD, DAMP and other neurodevelopmental/psychiatric disorders in 6-year-old children: epidemiology and co-morbidity.

M Landgren1, R Pettersson, B Kjellman, C Gillberg.   

Abstract

A total population of 589 6-year-old children were screened for neurodevelopmental/neuropsychiatric disorders by questionnaires to parents and preschool teachers, and by examination of motor abilities at the Child Health Center. Fifty screen-positive and fifty screen-negative children were assigned for complete neuropsychiatric assessment comprising a detailed history, psychiatric and neurodevelopmental assessment, neuropsychological examination and speech/language evaluation. Comprehensive diagnoses were made on the basis of all the available information. In the total population, 63 children (10.7%) with disorders were identified, 10 of whom had a diagnosis established before the study. The prevalence rates for deficits in attention, motor control and perception (DAMP) were 5.3 to 6.9%, for attention deficit hyperactivity disorder (ADHD) they were 2.4 to 4.0% and for mental retardation, 2.5%. Co-morbidity was established for ADHD on the one hand and DAMP, mental retardation and Tourette syndrome on the other. The findings suggest the need for a school entrant screening examination for the types of problems examined in this study.

Entities:  

Mesh:

Year:  1996        PMID: 8870611     DOI: 10.1111/j.1469-8749.1996.tb15046.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  25 in total

1.  Neurological soft signs and disruptive behavior among children of opiate dependent parents.

Authors:  Jeffrey J Wilson; Daniel S Pine; Abba Cargan; Rise B Goldstein; Edward V Nunes; Myrna M Weissman
Journal:  Child Psychiatry Hum Dev       Date:  2003

2.  Diagnosing coughs and colds.

Authors:  Jenny Doust; Chris Del Mar
Journal:  Br J Gen Pract       Date:  2004-01       Impact factor: 5.386

3.  Is dyspraxia a medical condition or a social disorder?

Authors:  Amanda Kirby
Journal:  Br J Gen Pract       Date:  2004-01       Impact factor: 5.386

4.  The worldwide prevalence of ADHD: is it an American condition?

Authors:  Stephen V Faraone; Joseph Sergeant; Christopher Gillberg; Joseph Biederman
Journal:  World Psychiatry       Date:  2003-06       Impact factor: 49.548

5.  Attention deficit disorder with developmental coordination disorders.

Authors:  M Landgren; B Kjellman; C Gillberg
Journal:  Arch Dis Child       Date:  1998-09       Impact factor: 3.791

Review 6.  The quantitative nature of autistic social impairment.

Authors:  John N Constantino
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

Review 7.  Variations in prevalence of attention deficit hyperactivity disorder worldwide.

Authors:  Maria Skounti; Anastas Philalithis; Emmanouil Galanakis
Journal:  Eur J Pediatr       Date:  2006-10-11       Impact factor: 3.183

Review 8.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

Review 9.  Deficits in attention, motor control, and perception: a brief review.

Authors:  C Gillberg
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

10.  Time trends and determinants of multiple development delays in Bavarian preschool children: a retrospective analysis from 1997 to 2010.

Authors:  Heribert Ludwig Stich; Riccardo Caniato; Alexander Krämer; Bernhard Baune
Journal:  Int J Public Health       Date:  2016-06-17       Impact factor: 3.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.